Exploring the Potential Use of Non-coding RNAs as Possible Biomarkers for Glioma. Literature Review

Abstract excerpt

Glioblastoma (GBM) is considered the most aggressive primary brain tumor with a high recurrence rate after treatment. Despite recent advances in molecular biology, the exact genetic and epigenetic pathways involved in gliomagenesis are not fully understood. Additionally, physicians currently lack robust non-invasive methods to diagnose and predict glioma with high accuracy. Cancer biomarkers, such as DNA, RNA, tra...

Topics

Open a Topic to create a Post that cites this publication.

• Cell Transformation, Neoplastic
• Gene Expression Regulation, Neoplastic
• Genetic Therapy
• Glioma
• Molecular Targeted Therapy
• RNA, Long Noncoding
• RNA Transport
• Structure-Activity Relationship

Identifiers and source

Literature Corpus work

74dcf581-c11e-55b0-9a55-52473385ea43

DOI

10.20944/preprints202503.2157.v1